baber/WOPTO huggingface dataset:
Patent CA-2562320-A1 (CA)
Title: Loose coffee apparatus, system and method
Inventor: RAHN CHRISTOPHER W
IPC: A47J31/06
Filed: 2005-04-07
Abstract: An infusion container (30) for use with a brewer (20). The infusion container (30) includes a body portion defining at least a portion of a cavity therein.  At least a portion of the body being liquid permeable. The infusion container liquid permeable portion facilitates brewing a beverage by allowing water to pass through the infusion container. The infusion container may be an individual structure which can be placed in and removed from the holder (30).  Additional components or group of components for use with the beverage holder (30). The infusion container provides structures and methods facilitating convenient use of a brewer which allows the user to use the type of substance and quantity of substance of their choice and efficiently clean the substance holder (30).
Patent CA-2562410-A1 (CA)
Inventor: KUSNETSOV VITALY NIKOLAEVICH
IPC: C11B1/10
Filed: 2005-04-04
Abstract: The invention relates to an oil and fat industry, in particular, to production of vegetable oils by a method of extraction by organic solvents. Aim of the invention is to provide such method of the vegetable oils extraction, such device for its implementation, and such extractor of a submersible type being a part of the device, which allow to increase intensity of mass exchange at the extraction stage, to increase concentration and purity of produced miscella, providing heightening output of the extracted oil and improving its quality, and also to obtain defatted meal suitable for further processing. For achieving these aims, the process is carried out at a temperature of phase transformation "fluid-vapor" in conditions of cavitation and intensive mixing of the solvent in non-mixed surrounding of a solid phase of the material under extraction, and solvent vapors, which are produced in this process, are removed, condensed and returned back into the process, providing the re-circulation of the solvent.
Patent CA-2563421-A1 (CA)
Inventor: VICENTELLI CLAUDIO
IPC: A63H33/26
Filed: 2005-01-24
Abstract: The system comprises a plurality of modular blocks (10, 14) of non~magnetic material, to be assembled to create compositions imitating, for exam~ple, a building, a doll, an animal, a vehicle or any other fancying assembly; a framework for connecting the blocks, comprises a plurality of magnetic frame members (11, 12) removably disposable into corresponding seatings (13, 17) in each modular block (10, 14), or between adjacent blocks of the composition.  The modular blocks (11, 12) and the magnetic frame members of framework have shoulder surfaces (18, 19) mutually engageable in the assembled condition of the assembly.
Patent CA-2566113-A1 (CA)
Inventor: PARK FA YOUNG
IPC: A45D29/00
Filed: 2005-05-12
Abstract: A method of and system for manufacturing a nail appliqué. A liquid nail enamel having high viscosity is provided and heated to at least 100 ~F. A layer of adhesive material is applied onto a substrate, and at least a first layer of the heated liquid nail enamel is applied atop the layer of adhesive material.  Multiple layers of nail enamel may be employed, optionally having particulate matter such as glitter or mica, optionally one or more of the layers being a clear coat layer. Heaters are employed between layer depositing stations to dry the previous layer at least partially before applying the next layer.  Additionally, multiple formulations of liquid nail enamel, of differing color and/or viscosity, may be passively mixed to form an interesting striped or swirled pattern.
Patent CA-2566185-A1 (CA)
Inventor: HEINIG ROLAND
IPC: A61K47/38
Filed: 2005-05-10
Abstract: The invention relates to novel controlled-release galenic dosage forms that contain the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphous forms thereof as the active ingredient, and to the production thereof. The invention also relates to the use of these novel galenic dosage forms as drugs and to their use in the production of drugs for use in the treatment and/or prevention of human and animal diseases.
Patent CA-2567868-A1 (CA)
Inventor: FUNAMURA SHIGEAKI
IPC: F16L29/02
Filed: 2006-11-10
Abstract: The present invention provides connector, for example a Luer connector in which a sealing element is provided such that when a connection is made to the connector, the sealing element is displaced into the connector, opening a fluid flow channel through the connector. Preferably, the sealing member includes a slit on a lower surface thereof to ease the displacement of the sealing member.
Patent CA-2568640-A1 (CA)
Title: Pharmaceutical composition containing irbesartan
Inventor: ZISMAN ERELA
IPC: A61K31/4184
Filed: 2005-06-02
Abstract: This invention relates to pharmaceutical compositions containing irbesartan, providing oral formulations with a high relative amount or concentration of irbesartan. In one embodiment, the present invention provides an oral formulation of irbesartan containing greater than 70% w/w irbesartan. In another embodiment, the invention provides an oral formulation of irbesartan which exhibits a dissolution profile according to which greater than about 85%  of the Irbesartan is dissolved within about 30 minutes using USP apparatus 2, placing the tablet in 1000mL of 0.1N hydrochloric acid at 37~C with paddle speed of 50 rpm. The formulation can optionally contain at least one additional active ingredient.
Patent CA-2568760-A1 (CA)
Inventor: WAUTERS ALBERT
IPC: B67D1/14
Filed: 2005-05-20
Abstract: La présente invention concerne un adaptateur de robinet (38) destiné à la distribution d'une boisson alcoolisée à partir d'un récipient (22), qui possède un épaulement (152), un bras de support (150), un tuyau de distribution, un dispositif de commande de restriction de flux (200) et un commutateur (300). Le tuyau de distribution est supporté par le bras de support et offre un passage de flux de boisson de façon à distribuer cette boisson à partir du récipient. Le tuyau de distribution possède au moins une partie paroi souple (86). Le dispositif de commande de restriction de flux est fixé de manière pivotante à un épaulement et se déplace entre la première position à distance du tuyau de distribution et une seconde position fermée destinée à partiellement enfoncer la partie paroi souple et à restreindre le flux de boisson à travers le passage. Le commutateur, lorsqu'on l'actionne, libère le dispositif de commande de restriction de flux de sa seconde position fermée. Ce commutateur d'adaptateur de robinet facilite la déconnexion du tuyau de distribution d'un récipient épuisé et le changement de ce tuyau de distribution.
Patent CA-2569518-A1 (CA)
Inventor: STOLL THIERRY
IPC: A61L27/28
Filed: 2004-06-03
Abstract: The device (14) serves for the impregnation of a porous bone replacement material (1) with an impregnation agent (5). The device (14) comprises a container (6) with a central axis (10) and a cavity (13) with a lid (8), whereby the container (2) has two sealable openings (3,4). The container (6) has an elastic means (19), arranged in the cavity (13), by means of which a clamping force may be exerted on a bone replacement material (1) inserted in the cavity (13). A single size of container is thus sufficient for housing variously sized implants and an implant placed in the cavity of the container is held, centered and protected against damage or breakage for example, by shaking back and forth or on transport of the container.
Patent CA-2569766-A1 (CA)
Title: Rotating armrest mechanism
Inventor: AMIN YOGIN
IPC: B60N2/75
Filed: 2005-06-06
Abstract: A seat assembly for a motor vehicle includes a seat back and an armrest rotatably coupled to the seat back for movement between a generally vertical, stowed position and a generally horizontal, use position. A guide member is disposed between the armrest and the seat back. The guide member includes a tube having an interior defining thread ridges. A guide pin extends through the tube and interconnects the armrest and seat back. The guide pin includes a helical screw thread portion for rotatably engaging the thread ridges to provide for lateral adjustment of the armrest towards and away from the seat back as the armrest moves between its respective stowed and use positions.
Patent CA-2571238-A1 (CA)
Title: Method of forming a tire
Inventor: NGUYEN GIA-VAN
IPC: B29D30/08
Filed: 2006-12-15
Abstract: A method of forming a tire includes a) forming a carcass, the carcass comprising at least one carcass reinforcing ply, a pair of opposing sidewalls, and a pair of bead portions, b) placing a belt structure on the carcass, c) forming a tread stock, d) placing the tread stock on the belt structure, and e) curing the tire in a mold wherein the mold has at least one rib to form a groove on the radially outer surface of the tire. A  tube is placed adjacent to or within the tread stock prior to the curing the tire, wherein the tube creates a buried groove in the cured tire. After wear of the tire tread to a preset level, the tube is exposed and opened during further wear to create increased grooving in the tread after the tire has experienced some tire wear.
Patent CA-2572647-A1 (CA)
Inventor: WELTEN WILHELMUS J C
IPC: B23Q11/00
Filed: 2005-07-01
Abstract: The invention relates to a device for holding and separating chippings and cooling liquid accumulating on machine tools, comprising: a holding tank (1) for holding the chippings and cooling liquid; a guide section (2); a discharge section (3), a chain-like closed conveying element (4), which is guided over return elements of which at least one is coupled to a rotating drive, and; a rotationally mounted filter drum (9) that is drive-connected to the conveying element. A covering element (11), which is invertedly channeled and which is parallel to the axis of the filter drum, is mounted in a fixed manner in the lower area of the filter drum (9), and extends at least over a portion of the length of the filter drum (9). The covering element (11) sealingly communicates, at its one end, with an opening in one wall of the drum housing, and the opening is connected to a suction line (17) that, in turn, is connected to a suction element (18), which is situated at a higher level and which discharges into a collection tank (19).
Patent CA-2573148-A1 (CA)
Inventor: MCGURK ERIN
IPC: A61B17/08
Filed: 2005-07-08
Abstract: This invention relates generally to a design of lung devices for safely performing a transthoracic procedure. In particular, the invention provides devices and methods of using these devices to access the thoracic cavity with minimal risk of causing pneumothorax or hemothorax. More specifically, the invention enables diagnostic and therapeutic access to a thoracic cavity using large bore instruments. This invention also provides a method for diagnostic and therapeutic procedures using a device capable of sealing the wound upon withdrawal of the device. The invention includes a device comprising an elongated body adapted to make contact with a tissue of a subject through an access hole, and a sealant delivery element. The invention also includes a method of performing tissue treatment or diagnosis in a subject.
Patent CA-2576789-A1 (CA)
Title: System and method for detecting decreased performance in a refrigeration system
Inventor: DOLL MARTIN LUTHER JR
IPC: G05B23/02
Filed: 2005-05-13
Abstract: Systems and methods are provided for detecting performance degradation in a refrigeration system 100. Specifically, the present invention provides systems and methods for detecting, at a very early stage, a low refrigerant charge 200 and degradation in condenser performance 300 of a refrigeration system 100.
Patent CA-2580139-A1 (CA)
Inventor: SHINHAMA KOICHI
IPC: C07D233/92
Filed: 2005-09-27
Abstract: The present invention provides a process for production of 2-chloro-4-nitroimidazole in a high yield and at a high purity by a simple operation in a safer manner involving a low risk of explosion or the like. The present invention provides a process for production of 2-chloro-4-nitroimidazole represented by the formula (1): comprising a reaction of a 1-alkoxyalkyl-2-bromo-4-nitroimidazole compound represented by the general formula (7):  wherein R1 represents a lower alkyl group, and n represents an integer of 1 to 3, with hydrogen chloride.
Patent CA-2580772-A1 (CA)
Title: Identification label
Inventor: WOOD MARK RONALD
IPC: G07C9/00
Filed: 2005-11-02
Abstract: An identification label (10) includes a microprocessor (38), a display (14), a keyboard (16) and a memory means for storing a security code and a plurality of editable screens of text, the label (10) being arranged to wake up from a sleep mode and display a start screen (50) selected from a plurality of screens of text for a predetermined period of time when the label is activated, and in which preselection of the screen of text be displayed and editing of screens of editable text can be effected only after inputting a security code via the keyboard (10).
Patent CA-2581417-A1 (CA)
Inventor: SUGIZAKI FUMITAKA
IPC: B26F1/14
Filed: 2005-09-20
Abstract: A biasing assembly for a punching device that includes a punch support member adapted to support a punch and including a head portion and a main portion extending from the head portion. The main portion has a recessed surface. A  retaining member is coupled to the punch support member with the punch support member being slidable with respect to the retaining member. A coupling member is disposed between the main portion of the punch support member and the retaining member. A portion of the coupling member engages the recessed surface. A biasing member is supported between the head portion of the punch support member and the retaining member. The punch support member is movable between at least first and second positions with respect to the coupling member.
Patent CA-2582919-A1 (CA)
Inventor: DUNUSSI-JOANNOPOULOS KYRIAKI
IPC: A61K39/38
Filed: 2005-10-11
Abstract: Compositions and methods for treating autoimmune diseases are described. In particular, the use of B cell depleting agents and cytotoxic drug/B cell depleting agent conjugates with a drug loading significantly higher than in previously reported procedures and with decreased aggregation and low conjugate fraction (LCF) in treating autoimmune diseases is described.  Combination therapies and compositions for treating autoimmune diseases, including the B cell depleting agents, conjugates and/or anti-cytokine agents, are also described.
Patent CA-2584899-A1 (CA)
Inventor: SUMINI MARCO
IPC: G21G1/04
Filed: 2005-10-21
Abstract: Device for the endogenous production of radioisotopes, particularly for PET, characterized by comprising: - a vacuum chamber (1), the inner surface of which at least partially treated to resistion implantation and inertised with respect to the nuclear reaction products, - a pair of electrodes (4,5) placed inside said vacuum chamber (1), - a capacitor bank (2), - means (3,16) to connect said capacitor bank (2) to said electrodes (4,5) to generate between the latter an electrical discharge, thus generating plasma and creating conditions for the unfolding of nuclear reactions that generate radioisotopes, - an overall inductance of the equivalent electric circuit of such device not exceeding 50 Nh - means (10) attached to said vacuum chamber (1) for the creation of a vacuum not higher than 10-6 torr - means (11) attached to said vacuum chamber (1) for the insertion, after creating the vacuum, of at least one reaction gas at a pressure apt to guarantee creation of the plasma during discharge and subsequent obtainment of confinement conditions of such plasma of the order of 1015 keV-s/cm3, and - means attached to said vacuum chamber (1) for the extraction of gas and its storage into a gas-chromatographic cylinder.
Patent CA-2587642-A1 (CA)
Title: Substituted heterocycles and methods of use
Inventor: FELLOWS INGRID
IPC: C07D401/12
Filed: 2005-11-29
Abstract: Selected compounds of Formula (I) are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases such as cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes. R - X - W - A - Y - R Formula (I) wherein R is X is O, S, NR2 or CR3R4 W is an substituted or unsubstituted aryl or substituted or unsubstituted 5- or 6- membered heteroaryl.
Patent CA-2587934-A1 (CA)
Title: Pyrrole derivatives having crth2 receptor antagonist activity
Inventor: BALA KAMLESH JAGDIS
IPC: C07D401/06
Filed: 2005-12-12
Abstract: There are provided according to the invention compounds of formula (I) as CRTh2 antagonists. In free or salt form, wherein R3, R4, R5, R6, Q, W and n are as described in the specification, process for preparing them, and their use as pharmaceuticals.
Patent CA-2594888-A1 (CA)
Title: Frame structure, wireless communication apparatus, and method for assigning the same
Inventor: HSIEH CHIN-CHIANG
IPC: H04L29/02
Filed: 2007-07-25
Abstract: A frame structure for an IEEE 802.16j standard, a wireless communication apparatus and a method for assigning the same in a wireless communication system are provided.  The wireless communication system comprises a base station (BS), a mobile station (MS), and a relay station (RS). The frame structure comprises an MS sub-frame and an RS  sub-frame.  The MS sub-frame is used for transmitting data between the RS and the MS. The RS  sub-frame is used for transmitting data between the RS and the BS.
Patent CA-2596454-A1 (CA)
Title: Procede de goniometrie en 1d ou 2d de sources diffuses
Inventor: MORGAND PHILIPPE
IPC: G01S3/74
Filed: 2005-02-01
Abstract: Procédé de goniométrie d'une ou de plusieurs sources diffuses, caractérisées par une ou des directions données et par un cône de diffusion et reçues par un réseau de plusieurs capteurs. Le procédé comporte au moins les étapes suivantes: a) décomposer le cône de diffusion en un nombre fini L de diffuseurs, à un diffuseur sont associés les paramètres (.theta. m p, .delta..theta. mpi , .DELTA. mp , .delta..DELTA. mpi ), b) combiner les vecteurs directeurs a(.theta. mp +.delta..theta. mpi , .DELTA. mp +,.delta..DELTA. mpi ) - associés aux L diffuseurs pour obtenir un vecteur (D(.theta., .DELTA., .delta..theta., .delta..DELTA.) .alpha. ou U(.theta., .DELTA.) ~(.delta..theta. ,.delta..DELTA., .alpha.)) dépendant au moins d'un des paramètres d'incidences et de déviation (.theta., .DELTA., .delta..theta., .delta..DELTA.) et du vecteur de combinaison .alpha., c) appliquer un critère de type MUSIC ou tout autre algorithme de goniométrie aux vecteurs D(.theta., .DELTA., .delta..theta., .delta..DELTA.) .alpha. ouU(.theta., .DELTA.) .beta.(.delta..theta., .delta..DELTA., .alpha.) obtenu à l'étape b) afin de déterminer au moins un des paramètres d'incidences .theta. mp , .DELTA. mp , .delta..theta. mp ,.delta..DELTA. m p du cône de diffusion associé.
Patent CA-2597433-A1 (CA)
Inventor: JIN YONG-SUK
IPC: H04W16/02
Filed: 2006-03-13
Abstract: A method of communicating feedback information between a mobile station and a base station by determining a need to request bandwidth allocation; providing information to a base station according to the determining, wherein the information indicates bandwidth allocation for a fast feedback channel, which is a robust channel; and performing communication with the base station upon bandwidth allocation according to the provided information.
Patent CA-2597473-A1 (CA)
Inventor: CLOUTIER GUY
IPC: G06T7/00
Filed: 2005-02-09
Abstract: The method for vascular elastography comprises: i) obtaining a sequence of radio-frequency (RF) images including pre-~tissue-motion and post-tissue-motion images in digital form of a vessel delimited by a vascular wall; the pre-tissue-motion and post-tissue-motion images being representative of first and second time-delayed configuration, of the whole vessel; ii) partitioning both the pre-tissue-motion and post~-tissue-motion images within the vascular wall into corresponding data windows; approximating a trajectory between the pre- and post-tissue-~motion for corresponding data windows; and using the trajectory for each data window to compute the full strain tensor in each data window, which allow determining the Von Mises coefficient. The method can be adapted for non-invasive vascular elastography (NIVE), for non-invasive vascular micro-elastography (MicroNIVE) on small vessels, and for endovascular elastography (EVE).
Patent CA-2600817-A1 (CA)
Title: Air-cooled fuel cell system
Inventor: MURATA SHIGEAKI
IPC: H01M8/02
Filed: 2006-03-10
Abstract: In an air-cooled fuel cell system (10) , a controlling apparatus (100) performs a temperature controlling process on the basis of the temperature of a fuel cell detected by a temperature sensor (500) . At this time, if the cell temperature is greater than a target temperature Ta and if the cell temperature is less than a threshold temperature Tth for defining a boundary between (i) a temperature group TGl, in which a change in a cell voltage is small relative to the stoichiometric ratio of the air for power generation, and (ii) a temperature group TG2, in which a change in the cell voltage is large relative to the stoichiometric ratio of the air for power generation, the controlling apparatus (100) controls an air supplying apparatus (210) to increase the amount of the air supplied to an air intake manifold (320) . If the cell temperature is equal to or greater than the threshold temperature Tth, the controlling apparatus (100) controls a variable valve (400) to increase the amount of the air flowing into a cooling air channel portion (315) without an increase in the amount of the air flowing into a power generating air channel portion 314.
Patent CA-2602093-A1 (CA)
Title: A cosmetic method of skin lightening
Inventor: HARICHIAN BIJAN
IPC: A61K8/37
Filed: 2006-03-06
Abstract: New 4-substituted resorcinol derivatives of general formula (I) and/or B and process for synthesizing same, cosmetic compositions and methods of using same, particularly for skin lightening: formula (I) and formula (B) wherein, X1 and/or X2 represents hydrogen (H); linear or branched, saturated or unsaturated C1-C12 alkyl, alkenyl, or acyl groups. Preferably, X1 and/or X2 represents hydrogen (H); linear or branched, saturated or unsaturated C1-C12 alkyl or acyl groups. R1 represents hydrogen (H); linear or branched, cyclic or acyclic, saturated or unsaturated C1-C12 alkyl, alkenyl, cycloalkyl, or cycloalkenyl group. Preferably, R1 represents hydrogen (H) or a C1 alkyl group (i.e, methyl group). More preferably, R1 represents hydrogen. n represents 0, 1. When n = 0, the ring is a cyclopentyl with or without one heteroatom from O, N or S and/or with or without one double bond. When n = 1, the ring is a cyclohexyl with or without one heteroatom from O, N or S and/or with or without one double bond. m represents an integer between 1 and 6.